Eli Lilly Scores Big Revenue Win but Wall Street Stays Cool

Eli Lilly just scored big with a 47.67% revenue surge thanks to Mounjaro sales! Their stock is on a wild ride, up 78% this year, but Wall Street is playing it cool with a modest outlook. Analysts are watching closely as Novo Nordisk could shake things up. Buckle up, investors—these next 18 months will be a thrilling rollercoaster!